275 related articles for article (PubMed ID: 15603891)
21. The current status of Helicobacter pylori vaccines: a review.
Kabir S
Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
24. Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice.
Zhou Z; Dong H; Huang Y; Yao S; Liang B; Xie Y; Long Y; Mai J; Gong S
J Med Microbiol; 2017 Jan; 66(1):83-89. PubMed ID: 27930268
[TBL] [Abstract][Full Text] [Related]
25. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice.
Velin D; Narayan S; Bernasconi E; Busso N; Ramelli G; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Michetti P; So A
Gastroenterology; 2011 Oct; 141(4):1273-82, 1282.e1. PubMed ID: 21703999
[TBL] [Abstract][Full Text] [Related]
26. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
[TBL] [Abstract][Full Text] [Related]
27. Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B.
Gu Q; Song D; Zhu M
FEMS Immunol Med Microbiol; 2009 Aug; 56(3):197-203. PubMed ID: 19453750
[TBL] [Abstract][Full Text] [Related]
28. Protection Against
Pan X; Ke H; Niu X; Li S; Lv J; Pan L
Front Immunol; 2018; 9():1003. PubMed ID: 29867978
[TBL] [Abstract][Full Text] [Related]
29. Novel methods of quantitative real-time PCR data analysis in a murine Helicobacter pylori vaccine model.
Roussel Y; Harris A; Lee MH; Wilks M
Vaccine; 2007 Apr; 25(15):2919-29. PubMed ID: 16905224
[TBL] [Abstract][Full Text] [Related]
30. Effects of vaccination by a recombinant antigen ureB138 (a segment of the beta-subunit of urease) against Helicobacter pylori infection.
Morihara F; Fujii R; Hifumi E; Nishizono A; Uda T
J Med Microbiol; 2007 Jun; 56(Pt 6):847-853. PubMed ID: 17510273
[TBL] [Abstract][Full Text] [Related]
31. Leptin receptor signaling is required for vaccine-induced protection against Helicobacter pylori.
Wehrens A; Aebischer T; Meyer TF; Walduck AK
Helicobacter; 2008 Apr; 13(2):94-102. PubMed ID: 18321299
[TBL] [Abstract][Full Text] [Related]
32. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
33. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
34. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
35. Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.
Nedrud JG; Bagheri N; Schön K; Xin W; Bergroth H; Eliasson DG; Lycke NY
PLoS One; 2013; 8(12):e83321. PubMed ID: 24391754
[TBL] [Abstract][Full Text] [Related]
36. [Cloning and sequence analysis of UreB of Helicobacter pylori isolated from children].
Zhou ZW; Deng QL; Xia HM; Geng LL; Liang WH; Xie YQ; Huang Y; Gong ST
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):877-80. PubMed ID: 20113650
[TBL] [Abstract][Full Text] [Related]
37. Identification of B-cell epitopes in urease B subunit of Helicobacter pylori bound by neutralizing antibodies.
Qiu Y; Wang YC; Tao HX; Zhan DW; Yuan SL; Wang P; Wang LC; Han XP; Li CS; Li JK; Liu CJ
Vaccine; 2010 Jul; 28(32):5220-7. PubMed ID: 20538095
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of Helicobacter pylori urease B protein and DNA vaccines in a mouse model.
Bégué RE; Cruz AR; Ramgoolam A; Breslin MB
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):493-6. PubMed ID: 18030223
[TBL] [Abstract][Full Text] [Related]
39. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
Harbour SN; Every AL; Edwards S; Sutton P
Helicobacter; 2008 Dec; 13(6):494-9. PubMed ID: 19166414
[TBL] [Abstract][Full Text] [Related]
40. Systemic immune responses to oral administration of recombinant attenuated Salmonella typhimurium expressing Helicobacter pylori urease in mice.
Liu XF; Hu JL; Quan QZ; Sun ZQ; Wang YJ; Qi F
World J Gastroenterol; 2005 Apr; 11(14):2154-6. PubMed ID: 15810083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
